Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influence of MDR1 genotype on indinavir and saquinavir pharmacokinetics in healthy volunteers.

Trial Profile

Influence of MDR1 genotype on indinavir and saquinavir pharmacokinetics in healthy volunteers.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Indinavir (Primary) ; Saquinavir (Primary) ; Midazolam
  • Indications HIV infections
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 04 May 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Actual patient number (81) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top